Medical device company Penumbra (NYSE:PEN) reported in Q4 CY2024, with sales up 10.8% year on year to $315.5 million. On the ...

Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s ...

Medical device company Penumbra (NYSE:PEN) will be reporting earnings tomorrow afternoon. Here’s what you need to know.

Penumbra stock gapped up Wednesday after the medtech company beat fourth-quarter expectations, though its revenue guidance came in shy. Shares of medical device company Penumbra (NYSE:PEN ...

Penumbra stock climbs after Q4 earnings surpass expectations, with sales up 10.8% Y/Y. Analysts raise price targets as the ...

Penumbra (NYSE:PEN – Get Free Report) had its price target hoisted by equities research analysts at Truist Financial from $285.00 to $325.00 in a note issued to investors on Wednesday,Benzinga reports ...

Penumbra (NYSE:PEN – Free Report) had its price objective increased by Robert W. Baird from $305.00 to $328.00 in a report ...

ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Penumbra Inc. (PEN) on Tuesday reported fourth-quarter net income of $33.7 million. The Alameda, California-based company said it had net income of 86 ...

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies ...

(AP) — Penumbra Inc. (PEN ... by Zacks Investment Research was for earnings of 91 cents per share. The medical device maker posted revenue of $315.5 million in the period, also surpassing ...